Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > IVIg Intravenous Immuno Globulin Treatment Report
What is IVIg Intravenous Immuno Globulin?

Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immune disorders including myaesthenia gravis and multifocial motor neuropathy. It is sometimes trialed on ALS patients during the diagnostic process to rule out other illnesses. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 19 4
Slow my ALS progress 10 1
Peripheral Neuropathy 4 0
Fatigue 1 0
specific antibody deficiency 1 0
Balance problems 1 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 20%
Mild
1 20%
None
3 60%

Most commonly reported side effects

Headaches
2 40%
Shortness of breath
1 20%
Hives
1 20%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking IVIg Intravenous Immuno Globulin. See all 11 dosages

  6 g monthly 25 mg monthly 30 mg monthly 40 g monthly 55 g monthly 100 g monthly 150 g monthly 180 mg monthly 800 mg monthly 3900 mL monthly 10000 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking IVIg Intravenous Immuno Globulin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
16 62% Did not seem to work: 62%
Course of treatment ended
12 46% Course of treatment ended: 46%
Doctor's advice
7 27% Doctor's advice: 27%
Side effects too severe
3 12% Side effects too severe: 12%
Expense
2 8% Expense: 8%
Other
1 4% Other: 4%

See all 26 patients who’ve stopped taking IVIg Intravenous Immuno Globulin

Currently Taking IVIg Intravenous Immuno Globulin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
1
4

Stopped Taking IVIg Intravenous Immuno Globulin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
7
10
5
2
1
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
5 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
2 40%
A little
1 20%
Not at all
2 40%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 20%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.